NDC 68084-896-95 - Venlafaxine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-896
- Requested NDC
- 68084-896-95
- Package NDCs from labels
- 68084-896-95, 68084-896-25
- Manufacturer
- American Health Packaging
- Effective date
- 2024-08-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Venlafaxine - American Health Packaging | American Health Packaging | 2024-08-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68084-896-25 | Venlafaxine | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | 9 | |
| 68084-896-95 | Venlafaxine | 1 in 1 BLISTER PACK | TABLET | 1 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-896-25 | EA - Each | 68084-896 | 923f6673-0749-4e20-adc0-178dc6bb6288 | 1 | 2015-10-02 |
| 68084-896-95 | EA - Each | 68084-896 | e45e6054-cc83-433d-b596-ee3a44e9087a | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | ST. MARY'S MEDICAL PARK PHARMACY | 35d3148b-52f3-197c-e063-6294a90a44e3 | 2025-05-23 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine | VENLAFAXINE | A-S Medication Solutions | 7bbdc9c5-a4b9-44d4-babc-46bd8c2e084a | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | ANDA077653 313584 7D7RX5A8MO |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b7eeeb-09ae-ffe6-e063-6294a90aba90 | 2025-05-07 | Warnings | 1K09F3G675 |
| Venlafaxine Hydrochloride | VENLAFAXINE | Rising Pharma Holdings, Inc. | 074f4478-e81b-45a2-ae85-ffd27bed940f | 2025-04-03 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| venlafaxine hydrochloride | VENLAFAXINE HYDROCHLORIDE | Dr.Reddys Laboratories Inc | f5c21429-d5d0-9f93-a465-6e5e0e19ebdd | 2025-03-26 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| RID Poison Ivy Rash Relief | CALAMINE AND ZINC OXIDE | Oystershell Consumer Health Inc. | 36c3af9a-2646-4427-e063-6394a90a2c5e | 2025-03-13 | Warnings | 1K09F3G675 |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 15c77ad7-7edc-4c36-ba3f-3ef05dfb12dc | 2025-02-27 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | AvPAK | 2efde38c-250e-d1b9-e063-6394a90a1b74 | 2025-02-25 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Calamine | FERRIC OXIDE RED | Preferred Pharmaceuticals Inc. | 326f3d80-c1bf-4cf0-a662-58e02ed7ee67 | 2025-02-12 | Warnings, Adverse reactions | 1K09F3G675 |
| Venlafaxine Hydrochloride | VENLAFAXINE | Preferred Pharmaceuticals Inc. | edefc932-d25d-4ead-b348-b3b6d9232091 | 2025-02-10 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine | VENLAFAXINE | NuCare Pharmaceuticals,Inc. | 017a84aa-0e1f-f560-e063-6294a90a9069 | 2025-02-04 | Boxed warning, Warnings, Adverse reactions | ANDA077653 313584 7D7RX5A8MO |
| Venlafaxine | VENLAFAXINE | NuCare Pharmaceuticals,Inc. | fe7de51e-8a81-fe68-e053-6294a90a7339 | 2025-02-04 | Boxed warning, Warnings, Adverse reactions | ANDA077653 313586 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE | NuCare Pharmaceuticals,Inc. | fda14f3f-b32c-42fe-e053-6294a90a103f | 2025-02-04 | Boxed warning, Warnings, Adverse reactions | 313580 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 2cf6e6ad-7d00-0db1-e063-6394a90ab1ec | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine HCL ER | VENLAFAXINE HCL ER | Direct_Rx | e20b7d9e-f755-4325-e053-2995a90ac45d | 2025-01-22 | Warnings, Adverse reactions | 7D7RX5A8MO |
| Prunus Iron | PRUNUS IRON | Uriel Pharmacy Inc. | 091be588-b62e-4919-8e9e-3edb9792d319 | 2025-01-22 | Warnings | 1K09F3G675 |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 2c2bb0e6-5a73-ff57-e063-6294a90a88d3 | 2025-01-20 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE | BluePoint Laboratories | 5efe1336-c796-4560-8110-a64c80eefb0c | 2025-01-10 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Ferrum Silicicum Urtica | FERRUM SILICICUM URTICA | Uriel Pharmacy Inc. | 09829ac4-c074-7315-e063-6394a90adf59 | 2025-01-07 | Warnings | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.